View in EDS HTML Full Text PDF Full Text

Real-World Efficacy of IL-23 Inhibitors in Psoriasis Affecting High-Impact Areas: Indirect Comparison of Tildrakizumab 200 mg, Risankizumab, and Guselkumab—IL PSO (Italian Landscape Psoriasis).

Saved in:
Bibliographic Details
Title: Real-World Efficacy of IL-23 Inhibitors in Psoriasis Affecting High-Impact Areas: Indirect Comparison of Tildrakizumab 200 mg, Risankizumab, and Guselkumab—IL PSO (Italian Landscape Psoriasis).
Authors: Trovato, Emanuele1 (AUTHOR), Cartocci, Alessandra1 (AUTHOR), Gaiani, Francesca2 (AUTHOR), Messina, Francesco2 (AUTHOR), Mastorino, Luca3 (AUTHOR), Macagno, Nicole3 (AUTHOR), Carugno, Andrea4 (AUTHOR), Campoli, Marco4 (AUTHOR), Fargnoli, Maria Concetta5 (AUTHOR), Lora, Viviana5 (AUTHOR), Rossi, Agnese6 (AUTHOR), Gioacchini, Helena7 (AUTHOR), Potestio, Luca8 (AUTHOR), D'Agostino, Giovanni Marco7 (AUTHOR), Maurelli, Martina9 (AUTHOR), Girolomoni, Giampiero9 (AUTHOR), Romanelli, Marco10 (AUTHOR), Dini, Valentina10 (AUTHOR), Loconsole, Francesco11 (AUTHOR), Satolli, Francesca12 (AUTHOR)
Source: Dermatology & Therapy. Mar2026, Vol. 16 Issue 3, p1675-1692. 18p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:21938210
DOI:10.1007/s13555-026-01662-9